2025 C2D2 Symposium Speaker Evaluations

For each speaker, please score your overall impression of their presentation and handling of questions on a scale of 1-20.

Here is a rough scale.

1 - Speaker was unprepared and disorganized.

10 - OK, but could use some work.

15 - Good! Engaging. Clear message. Well-timed.

20 - Amazing! Really couldn't be any better.

Question Title

* 1. Evgenia Momchilova: Transcriptional regulation of non-coding RNA in heat shock.

1

10

20

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 2. Please feel free to provide constructive comments for Eva

Question Title

* 3. Arlo Court: Imaging mtDNA release in live cells.

1

10

20

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 4. Please feel free to provide constructive comments for Arlo

Question Title

* 5. Naseem Givzad : Investigating pathogenicity of the P369R Kv7.5 channel variant associated with intellectual disability and epileptic encephalopathies.

1

10

20

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 6. Please feel free to provide constructive comments for Naseem

Question Title

* 7. Arlene Gidda: Exploring therapeutic vulnerabilities in pancreatic neuroendocrine neoplasms.

1

10

20

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 8. Please feel free to provide constructive comments for Arlene

Question Title

* 9. Soma Roy: Guanidinium-based Nucleic Acid Concentrator for Point-of-Care Diagnostics.

1

10

20

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 10. Please feel free to provide constructive comments for Soma

Question Title

* 11. Homa Hamledari: Exploring the molecular mechanisms of TNNT2-linked hypertrophic cardiomyopathy using human induced pluripotent stem cell-derived cardiomyocytes during early and later stages of maturation.

1

10

20

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 12. Please feel free to provide constructive comments for Homa

Question Title

* 13. Jonathan Goldman: Kinetic analysis of HIF-1 Signaling in Skeletal Muscle.

1

10

20

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 14. Please feel free to provide constructive comments for Jonathan.

Question Title

* 15. Rasool Khaef Panah: Investigating the Role of β2 Integrins during Antibody-Dependent Phagocytosis of B-Cell Lymphomas Using an AI-Driven Imaging Approach.

1

10

20

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 16. Please feel free to provide constructive comments for Rasool

Question Title

* 17. Shaianne Stein: Extracellular Cathepsin S from activated mesenchymal stromal cells (MSCs) modulates angiogenesis.

1

10

20

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 18. Please feel free to provide constructive comments for Shaianne

Question Title

* 19. Karm Grewal: Characterizing human CDK19 patient variants using Drosophila melanogaster.

1

10

20

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 20. Please feel free to provide constructive comments for Karm.

Question Title

* 21. Tong Tong Wu: Characterizing the Antimicrobial Properties of Mesenchymal Stromal Cells.

1

10

20

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 22. Please feel free to provide constructive comments for Tong Tong

Question Title

* 23. Kin Lam Wong: A bioprinting approach for high-throughput production of micropatterned neuroepithelial tissues and modeling TSC2-deficient brain malformations.

1

10

20

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 24. Please feel free to provide constructive comments for Kin Lam

Question Title

* 25. Ibrahim King: Fabrication of a 3D Printed Scratch Assay Tool as a Low-Cost Alternative to Commercial Devices.

1

10

20

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 26. Please feel free to provide constructive comments for Ibrahim

Question Title

* 27. Ece Yücel: Exploring Synergies Between Oncogenic Factors HIPK and SIK.

1

10

20

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 28. Please feel free to provide constructive comments for Ece

Question Title

* 29. Samira Ebrahimi: Regnase-1 Precisely Cleaves NFKBIZ RNA and Triggers Uridylation: A Destabilization Mechanism Impaired in Lymphoma and Viral Infection.

1

10

20

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 30. Please feel free to provide constructive comments for Samira

Question Title

* 31. Yelyzaveta Kharkova: Inhibition of Bacterial RNA Polymerase by the Combined Action of a Small Regulatory Non-Coding RNA and Rifampicin: Potential for New Types of Antibiotics.

1

10

20

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 32. Please feel free to provide constructive comments for Yelyzaveta.